SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001372514-23-000145
Filing Date
2023-10-03
Accepted
2023-10-03 16:45:28
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1696365916.html 4  
1 FORM 4 wk-form4_1696365916.xml 4 3909
  Complete submission text file 0001372514-23-000145.txt   5399
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Stengone Carmine N. (Reporting) CIK: 0001861519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 231304696